StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.67−0.12 (-0.81%)

Close on Nov 18, 2026Market cap $292.19MP/E 35.8Yield –

InfuSystem revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

InfuSystem's revenue for the twelve months ending Jun 30, 2026 was $143.34M, up 2.5% year over year. For fiscal 2025 it was $143.44M, up 6.4% from the year before. Over ten years it grew 7.4% a year on average. The highest annual figure on record is $143.44M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$143.44M+6.4%
FY2024Dec 31, 2024$134.86M+7.2%
FY2023Dec 31, 2023$125.79M+14.4%
FY2022Dec 31, 2022$109.91M+7.4%
FY2021Dec 31, 2021$102.38M+5.1%
FY2020Dec 31, 2020$97.39M+20.1%
FY2019Dec 31, 2019$81.12M+20.8%
FY2018Dec 31, 2018$67.14M-5.5%
FY2017Dec 31, 2017$71.08M+0.8%
FY2016Dec 31, 2016$70.50M-0.1%
FY2015Dec 31, 2015$70.54M+6.1%
FY2014Dec 31, 2014$66.49M+6.8%
FY2013Dec 31, 2013$62.28M+5.9%
FY2012Dec 31, 2012$58.83M+7.7%
FY2011Dec 31, 2011$54.64M+15.7%
FY2010Dec 31, 2010$47.23M+21.2%
FY2009Dec 31, 2009$38.96M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$36.93M+2.6%
Q1 FY2026Mar 31, 2026$33.68M-3.0%
Q4 FY2025Dec 31, 2025$36.23M+7.0%
Q3 FY2025Sep 30, 2025$36.49M+3.3%
Q2 FY2025Jun 30, 2025$36.00M+6.8%
Q1 FY2025Mar 31, 2025$34.72M+8.5%
Q4 FY2024Dec 31, 2024$33.85M+6.5%
Q3 FY2024Sep 30, 2024$35.32M+10.7%
Q2 FY2024Jun 30, 2024$33.70M+6.2%
Q1 FY2024Mar 31, 2024$32.00M+5.4%
Q4 FY2023Dec 31, 2023$31.77M+10.2%
Q3 FY2023Sep 30, 2023$31.91M+17.0%
Q2 FY2023Jun 30, 2023$31.74M+17.4%
Q1 FY2023Mar 31, 2023$30.37M+13.5%
Q4 FY2022Dec 31, 2022$28.83M+8.7%
Q3 FY2022Sep 30, 2022$27.28M+2.7%
Q2 FY2022Jun 30, 2022$27.04M+8.9%
Q1 FY2022Mar 31, 2022$26.76M+9.4%
Q4 FY2021Dec 31, 2021$26.52M+7.3%
Q3 FY2021Sep 30, 2021$26.57M+5.7%
Q2 FY2021Jun 30, 2021$24.83M-4.5%
Q1 FY2021Mar 31, 2021$24.46M+13.5%
Q4 FY2020Dec 31, 2020$24.71M+13.8%
Q3 FY2020Sep 30, 2020$25.13M+16.9%
Q2 FY2020Jun 30, 2020$26.00M+31.8%
Q1 FY2020Mar 31, 2020$21.55M+18.5%
Q4 FY2019Dec 31, 2019$21.71M+23.6%
Q3 FY2019Sep 30, 2019$21.49M+28.9%
Q2 FY2019Jun 30, 2019$19.72M+20.2%
Q1 FY2019Mar 31, 2019$18.19M+10.4%
Q4 FY2018Dec 31, 2018$17.56M-7.0%
Q3 FY2018Sep 30, 2018$16.68M-5.2%
Q2 FY2018Jun 30, 2018$16.42M-3.1%
Q1 FY2018Mar 31, 2018$16.48M-6.6%
Q4 FY2017Dec 31, 2017$18.89M+12.1%
Q3 FY2017Sep 30, 2017$17.59M+2.1%
Q2 FY2017Jun 30, 2017$16.94M–
Q1 FY2017Mar 31, 2017$17.65M–
Q4 FY2016Dec 31, 2016$16.85M–
Q3 FY2016Sep 30, 2016$17.23M–

More InfuSystem figures

See a number that looks wrong?